Showing results (631-640 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|May 21, 2025
Inhibition Mechanism of Ketamine-Apatinib by CYP2C9 and 3A4: A Prediction of Possible Drug-Drug InteractionXiang Zheng, Haiyan Chen, Dan Lin, et al.Biopharmaceutics & Drug Disposition|March 24, 2025
Species Differences in Carboxylesterases Among Humans, Cynomolgus Monkeys, and Mice in the Hydrolysis of Atorvastatin DerivativesMasato Takahashi, Sachiko Sakai, Kohei Takahashi, et al.Biopharmaceutics & Drug Disposition|April 17, 1999
Absorption and disposition of a tripeptoid and a tetrapeptide in the ratY Wang, H Lin, R Tullman, et al.Biopharmaceutics & Drug Disposition|October 2, 2003
Pharmacokinetics and pharmacodynamics of azosemideOk K Suh, So H Kim, Myung G LeeBiopharmaceutics & Drug Disposition|October 2, 2003
Comparison of ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified Ussing chambersR M Menon, W H BarrBiopharmaceutics & Drug Disposition|April 16, 2013
Therapeutic drug monitoring and pharmacokinetic compartmental analysis of sulpiride double-peak absorption profile after oral administration to human volunteersSally A HelmyBiopharmaceutics & Drug Disposition|June 25, 2013
Population pharmacokinetics of tolvaptan in healthy subjects and patients with hyponatremia secondary to congestive heart failure or hepatic cirrhosisScott A Van Wart, Susan E Shoaf, Suresh Mallikaarjun, et al.Biopharmaceutics & Drug Disposition|April 1, 1990
Influence of lovastatin on the pharmacokinetics, toxicity and immunologic response of cyclosporine in the obese Zucker ratK L Berens, K Vadiei, L J Brunner, et al.Biopharmaceutics & Drug Disposition|May 1, 1990
Pharmacokinetic aspects of the sublingual administration of vincamineJ M Aiache, M C Delatte, P P Leblanc, et al.Biopharmaceutics & Drug Disposition|May 1, 1990
Oxcarbazepine disposition: preliminary observations in patientsA Kumps, C WurthPageof 214